Jaques van Heerden, Bénédicte Brichard, Dries Ruttens, Stijn Verhulst, Katleen Balliauw, Nicolette Moes, Hilde Dotremont, Anne Uyttebroeck, Joris Verlooy, Toon Van Genechten, Liesbeth Vanheeswijck, Kim Van Hoorenbeeck, Machiel van den Akker
{"title":"儿童囊性纤维化和儿童癌症的临床特点和特殊处理:病例系列和文献回顾。","authors":"Jaques van Heerden, Bénédicte Brichard, Dries Ruttens, Stijn Verhulst, Katleen Balliauw, Nicolette Moes, Hilde Dotremont, Anne Uyttebroeck, Joris Verlooy, Toon Van Genechten, Liesbeth Vanheeswijck, Kim Van Hoorenbeeck, Machiel van den Akker","doi":"10.1002/1545-5017.70295","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cystic fibrosis (CF) is an autosomal recessive inherited chronic disorder that predisposes adults to gastrointestinal malignancies. The latter has not been observed in children, perhaps due to the limited documentation of the copresentation of childhood cancer in CF. The following review will provide a comprehensive overview of the relevant literature on this subject.</p><p><strong>Methodology: </strong>The objective of this study was to identify cases in Belgium over a 25-year period and to review the literature for similar cases. Our secondary objective was to identify areas of attention during oncological management based on the clinical cases and extant literature.</p><p><strong>Results: </strong>Four cases were diagnosed in Belgium and a further 10 cases were identified in the literature. These fourteen cases exhibited a 1:1 male-to-female ratio. Four cases were hematological malignancies, and 10 cases were solid tumors, predominantly neuroblastomas and osteosarcomas. No specific age group predominated at the time of diagnosis of the malignancy. As the literature indicated that organs were at risk in all systems, at increased risk for treatment toxicities, and a need for increased nutritional and antimicrobial support. The threshold for intervention with supportive care should be substantially lower than in non-CF patients. These patients are predisposed to an increased risk for premature morbidity and mortality.</p><p><strong>Conclusion: </strong>Short and long-term CF-specific survivorship care plans should be developed based on both disease entities in anticipation of compounded risks for early cardio-respiratory disease and an increased awareness of secondary cancer screening. Research into the copresentation of these diseases should be promoted.</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e70295"},"PeriodicalIF":2.3000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical Characteristics and Specific Management Considerations in Children With Cystic Fibrosis and Childhood Cancer: Case Series and Review of the Literature.\",\"authors\":\"Jaques van Heerden, Bénédicte Brichard, Dries Ruttens, Stijn Verhulst, Katleen Balliauw, Nicolette Moes, Hilde Dotremont, Anne Uyttebroeck, Joris Verlooy, Toon Van Genechten, Liesbeth Vanheeswijck, Kim Van Hoorenbeeck, Machiel van den Akker\",\"doi\":\"10.1002/1545-5017.70295\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Cystic fibrosis (CF) is an autosomal recessive inherited chronic disorder that predisposes adults to gastrointestinal malignancies. The latter has not been observed in children, perhaps due to the limited documentation of the copresentation of childhood cancer in CF. The following review will provide a comprehensive overview of the relevant literature on this subject.</p><p><strong>Methodology: </strong>The objective of this study was to identify cases in Belgium over a 25-year period and to review the literature for similar cases. Our secondary objective was to identify areas of attention during oncological management based on the clinical cases and extant literature.</p><p><strong>Results: </strong>Four cases were diagnosed in Belgium and a further 10 cases were identified in the literature. These fourteen cases exhibited a 1:1 male-to-female ratio. Four cases were hematological malignancies, and 10 cases were solid tumors, predominantly neuroblastomas and osteosarcomas. No specific age group predominated at the time of diagnosis of the malignancy. As the literature indicated that organs were at risk in all systems, at increased risk for treatment toxicities, and a need for increased nutritional and antimicrobial support. The threshold for intervention with supportive care should be substantially lower than in non-CF patients. These patients are predisposed to an increased risk for premature morbidity and mortality.</p><p><strong>Conclusion: </strong>Short and long-term CF-specific survivorship care plans should be developed based on both disease entities in anticipation of compounded risks for early cardio-respiratory disease and an increased awareness of secondary cancer screening. Research into the copresentation of these diseases should be promoted.</p>\",\"PeriodicalId\":19822,\"journal\":{\"name\":\"Pediatric Blood & Cancer\",\"volume\":\" \",\"pages\":\"e70295\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2026-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Blood & Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/1545-5017.70295\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/4/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Blood & Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/1545-5017.70295","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Clinical Characteristics and Specific Management Considerations in Children With Cystic Fibrosis and Childhood Cancer: Case Series and Review of the Literature.
Background: Cystic fibrosis (CF) is an autosomal recessive inherited chronic disorder that predisposes adults to gastrointestinal malignancies. The latter has not been observed in children, perhaps due to the limited documentation of the copresentation of childhood cancer in CF. The following review will provide a comprehensive overview of the relevant literature on this subject.
Methodology: The objective of this study was to identify cases in Belgium over a 25-year period and to review the literature for similar cases. Our secondary objective was to identify areas of attention during oncological management based on the clinical cases and extant literature.
Results: Four cases were diagnosed in Belgium and a further 10 cases were identified in the literature. These fourteen cases exhibited a 1:1 male-to-female ratio. Four cases were hematological malignancies, and 10 cases were solid tumors, predominantly neuroblastomas and osteosarcomas. No specific age group predominated at the time of diagnosis of the malignancy. As the literature indicated that organs were at risk in all systems, at increased risk for treatment toxicities, and a need for increased nutritional and antimicrobial support. The threshold for intervention with supportive care should be substantially lower than in non-CF patients. These patients are predisposed to an increased risk for premature morbidity and mortality.
Conclusion: Short and long-term CF-specific survivorship care plans should be developed based on both disease entities in anticipation of compounded risks for early cardio-respiratory disease and an increased awareness of secondary cancer screening. Research into the copresentation of these diseases should be promoted.
期刊介绍:
Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.